RecruitingNot ApplicableNCT02438904
Compassionate Access of the Miltenyi Device for CD34+ Cell Selection
Sponsor
M.D. Anderson Cancer Center
Enrollment
200 participants
Start Date
May 6, 2015
Study Type
INTERVENTIONAL
Conditions
Summary
Objectives: Primary Objective To provide compassionate access to the Miltenyi device for CD34+ cell infusions to patients who experience poor graft function after stem cell transplantation (SCT).
Eligibility
Inclusion Criteria1
- \) Patients who have poor or no graft function post stem cell transplantation.
Exclusion Criteria1
- N/A
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
BIOLOGICALCD34 Positive Stem Cell Infusion
Participants infused by vein with around 1 - 4 million/kg CD34+ selected cells.
DEVICEMiltenyi device
Miltenyi device is used for CD34+ cell infusions) to patients who experience poor graft function after stem cell transplantation (SCT).
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT02438904